Biotech MavenHot Analyst Reads4 Hot Analyst Reads For Wednesday, July 25th Biotech MavenViewray Received its Third Buy in a Row - MarketsAfter Jefferies and B.Riley FBR gave Viewray (NASDAQ: VRAY) a Buy rating last month, the company received another Buy, thiswww.markets.co
